Skip to main content

3 Result(s)

within R Go Remove this filter Medicine & Public Health Remove this filter

and

  1. Article

    Open Access

    Correction: Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design

    I. Vaxman, S. K. Kumar, F. Buadi, M. Q. Lacy, D. Dingli, Y. Hwa, A. Fonder… in Leukemia (2024)

    Download PDF (487 KB) View Article

  2. Article

    Open Access

    Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design

    I. Vaxman, S. K. Kumar, F. Buadi, M. Q. Lacy, D. Dingli, Y. Hwa, A. Fonder… in Leukemia (2021)

    Download PDF (699 KB) View Article

  3. No Access

    Article

    Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

    Immunoparesis is an adverse prognostic marker in plasma cell proliferative disorders. Its impact in AL amyloidosis has not been explored in depth. Newly diagnosed AL amyloidosis patients (n=998) were evaluated fo...

    E Muchtar, A Dispenzieri, S K Kumar, F K Buadi, M Q Lacy, S Zeldenrust… in Leukemia (2017)